4th World Congress on Rare Diseases and Orphan Drugs June 11-12, 2018 Dublin, Ireland

Tiziana Greggi Specialized works in Orthopedics and Traumatology, at the University of Bologna, Specialized in Biomedical Technologies, at the University of Bologna and she is the Head of Simple Departmental Structure: Spinal deformity surgery. She has worked in the Division of Spine Surgery of the Rizzoli Institute, first as an assistant and then as a senior manager. From 2000 to 2008 he received temporary positions as Director of a complex structure. From the end of this position to date has been responsible for the Organizational Module "the spinal deformities in pediatric age and associated with rare diseases" in the same Division. He is also responsible for a specialized clinic dedicated to the study and treatment of severe spinal deformities associated with rare diseases at the Rizzoli Orthopedic Institute. He is currently Head of the Departmental Simple Structure: Spinal deformity surgery

Spinal deformit, Spinal Surgery

Dr. Bhat has over 18 years’ experience in drug discovery and development and prior to founding Reviva, he held research positions at XenoPort, ARYx Therapeutics and Higuchi Biosciences Center in the United States. Dr. Bhat has received a global post-doctoral training at the University of Kansas, USA, the Georg-August-Universität, Göttingen, Germany and the Université du Maine, France. In 1995, he was selected for the Alexander von Humboldt fellowship, an internationally recognized award for young scientists to pursue advanced research in Germany. Dr. Bhat received his Ph.D. in synthetic organic chemistry from the Central University (NEHU), India and has authored over 15 research papers published in peer-reviewed scientific journals. Dr. Bhat is an inventor on more than 100 filed patents and over 35 granted patents

Drug Discovery

The Department of Department of Infectious Diseases / Tropical Medicine, Nephrology and Rheumatology at St. Georg Hospital in Leipzig is about regional focus clinic and competence center for infectious diseases for the state of Saxony

Infectious Diseases & Resarch

Stef Stienstra works internationally for several medical and biotech companies as scientific advisory board member and is also an active reserve-officer of the Royal Dutch Navy in his rank as Commander (OF4). For the Dutch Armed Forces he is CBRNe specialist with focus on (micro)biological and chemical threats and medical- and environmental functional specialist within the 1st CMI (Civil Military Interaction) Battalion of the Dutch Armed Forces. For Expertise France he is now managing an EU CBRN CoE public health project in West Africa. In his civilian position he is at this moment developing with MT-Derm in Berlin (Germany) a novel interdermal vaccination technology as well as a new therapy for cutaneous leishmaniasis for which he has won a Canadian ‘Grand Challenge’ grant. With Hemanua in Dublin (Ireland) he has developed an innovative blood separation unit, which is also suitable to produce convalescent plasma for Ebola Virus Disese therapy. He has finished both his studies in Medicine and in Biochemistry in The Netherlands with a doctorate and has extensive practical experience in cell biology, immuno-haematology, infectous diseaases, biodefense and transfusion medicine. His natural business acumen and negotiation competence helps to initiate new successful businesses, often generated from unexpected combinations of technologies.

Infectious Diseases

An expert in international health initiatives, health in developing nations, HIV/AIDS research

Infection Diseases, Neglected Diseases